Home > About GAMMAGARD LIQUID > What to Expect

GAMMAGARD LIQUID for IV Administration

With GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10%, you and your doctor can decide whether IV or SubQ administration is best for you. This decision will shape your infusion experience, including where and how often you receive treatment and whether you, your caregiver, or your healthcare professional administers the infusion.1

IVIG Treatment

  • GAMMAGARD LIQUID for IV administration is administered by a healthcare professional at a single infusion site into a vein1
  • Since it is infused into a vein, the antibodies immediately begin circulating in your bloodstream1,2
  • IV treatment can be given at a hospital or clinic or at home, every 3 or 4 weeks1
  • Your dose and infusion rate will be prescribed based on your clinical response and tolerability.1

What to Expect With IV Treatment

Before the infusion:

  • Drink lots of fluids the day before and day of the infusion.3 (Check with your doctor if you have any medical conditions that limit your water intake)
  • Bring a book, music player, or other materials to keep yourself occupied during the infusion
  • Many hospitals will have you sign a consent form to ensure you are informed of the potential risks of your treatment3
  • The nurse will place the IV catheter in the vein1

During the infusion:

  • Relax and sit comfortably3
  • Let the nurse know if you feel uncomfortable at any time
  • Some common side effects such as headache, fatigue, fever, nausea and chills may occur with GAMMAGARD LIQUID IV1
  • If you experience any serious side effects such as blood clots, kidney problems, hives or trouble breathing, stop the infusion, and contact your doctor or emergency services immediately1

After the infusion:

  • Continue to drink fluids and remain hydrated3
  • Report any side effects to your doctor or nurse1
  • Record your infusion in your logbook3

References: 1. GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% [Prescribing Information]. Westlake Village, CA: Baxalta US Inc. 2. Blaese RM, Bonilla FA, Stiehm ER, Younger ME, eds. Patient & Family Handbook for Primary Immunodeficiency Diseases. 5th ed. Towson, MD: Immune Deficiency Foundation; 2013. 3. Younger MEM, ed. IDF Guide for Nurses: Immunoglobulin Therapy for Primary Immunodeficiency Diseases. 4th ed. Towson, MD: Immune Deficiency Foundation; 2016.


  • Sign up to get access to experienced Patient and Nurse Advocates, insurance and financial support, useful tools, and more.
    Enroll Now
  • Ask an Advocate Questions about PI or PI treatments? Our trained Patient and Nurse Advocates can help, and asking your question is easy with our Ask An Advocate feature.
    Start Getting Answers

Gammagard Liquid MyIgCoPayCard Program Terms and Conditions

This manufacturer's coupon program is not valid for prescriptions reimbursed, in whole or in part, by Medicaid, Medicare, Medigap, VA, DoD, TRICARE, or any other federal or state healthcare programs, including state pharmaceutical assistance programs, and where prohibited by the health insurance provider or by law

Shire's MyIgCoPayCard program provides a maximum total benefit of $5,000 for eligible out-of-pocket costs and expires 12 months from date of activation. Eligible costs include deductible, copayment, and co-insurance costs for eligible Shire IG (Immunoglobulin) products. Non-medication expenses, such as ancillary supplies or administration-related costs, are not eligible.

To be eligible, patients must: 1. be starting or receiving treatment with (and have current prescription for) an eligible Shire IG product with an ICD-10 for a diagnosis of Primary Immunodeficiency; and 2. have commercial insurance that covers medication costs for prescribed Shire IG product and allows for CoPay assistance; and 3. be two (2) years old or older.

Acceptance of this offer must be consistent with the terms of benefits provided by patient's health insurance provider.

Offer limited to one card per person and may not be combined with any other coupon, discount, prescription savings card, rebate, free trial, patient assistance, or other offer.

This program is only valid for residents of the United States.

Shire reserves the right to change or discontinue this program at any time without notice.

This is not health insurance.


Add to patient instructions:

If your insurance situation changes, it is your responsibility to notify MyIgSource's CoPay assistance program.

© 2017 Shire. All rights reserved.

SHIRE and the Shire Logo are registered trademarks of Shire Pharmaceutical Holdings Ireland Limited or its affiliates. Gammagard Liquid is a trademark or registered trademark of Baxalta Incorporated, a wholly owned, indirect subsidiary of Shire plc.

S30515 04/17

Please expand for Indication and Important Safety Information.

Selected Important Safety Information for GAMMAGARD LIQUID
  • GAMMAGARD LIQUID can cause decreased kidney function or kidney failure, blood clots in the heart, brain, lungs or elsewhere in the body. Call your healthcare professional or go to your emergency department right away if you have: Reduced urination, sudden weight gain, or swelling in your legs. These could be signs of a kidney problem. Pain, swelling, warmth, redness, or a lump in your legs or arms. These could be signs of a blood clot.
  • Do not take GAMMAGARD LIQUID if you have a known history of a severe allergic reaction to IgG or other blood products.